Salt CompositionTrihexyphenidyl 0.25mg
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Used In
Treatment of Parkinson's disease / Treatment of Drug induced abnormal movements
Customers also bought
More About Zoxol 0.25mg Tablet 24s
Benefits
In Treatment of Parkinson's disease Parkinson?s disease (PD) is a disorder of the central nervous system. It makes the muscles stiff which causes difficulties in standing and walking. PD also causes tremors and loss of balance. Zoxol 0.25mg Tablet helps to treat the symptoms of Parkinson's Disease. It relaxes the stiff muscles and helps in easy movement without losing balance. Zoxol 0.25mg Tablet is also used to treat side effects like abnormal movements caused by antipsychotic drugs. It is advisable not to stop this medicine without consulting your doctor. This is because a sudden stoppage can cause symptoms of Parkinson's disease to return. You can see that the drug is working if you are able to do your daily activities more easily and have a more active and better quality of life. In Treatment of Drug induced abnormal movements Zoxol 0.25mg Tablet is also used to treat side effects like abnormal movements caused by antipsychotic drugs. It helps restore normal body posture as well as control over muscle movements in the body. This will enable you to lead a normal life and improve your ability to carry out daily activities.
Side Effects
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
How to use
Follow your doctor's guidance regarding the dose and duration of this medication. Ingest it without breaking or crushing. Do not chew, crush or break it. Zoxol 0.25mg Tablet is to be taken empty stomach.
How it works
Zoxol 0.25mg Tablet is an anticholinergic medication. It works by decreasing the activity of a chemical messenger (acetylcholine) in the brain. This improves muscle control and reduces stiffness in Parkinson's disease. It also improves movement disorder (restlessness, involuntary movements or muscle spasm) caused by certain other medicines.
Unsafe: Avoid consuming alcohol with Zoxol 0.25mg Tablet as it is deemed unsafe.
Seek medical advice from your doctor: Zoxol 0.25mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.
Safe when prescribed by an expert: Zoxol 0.25mg Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Not Safe: Zoxol 0.25mg Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur. Zoxol 0.25mg Tablet can cause blurring of vision, dizziness, mild nausea, and mental confusion in some cases. This may affect your ability to drive.
Seek medical advice from your doctor: There is limited information available on the use of Zoxol 0.25mg Tablet in patients with kidney disease. Doctor consultation is advised. Patients with kidney disease should be closely monitored by a doctor while taking this medicine.
Seek medical advice from your doctor: There is limited information available on the use of Zoxol 0.25mg Tablet in patients with liver disease. Doctor consultation is advised.
What if I forget to take it?
If a dose of Zoxol 0.25mg Tablet is missed, take it promptly. However, if your next dose is approaching, skip the missed dose and resume your regular schedule. Avoid doubling the dose.
Manufacturer Address
56-57, INDUDTRIAL AREA, MAXI ROAD UJJAIN MP 456010 IN
References
Stahl SM, editor. Trihexyphenidyl. In: Stahl's Essential Pschopharmacology: Prescriber's Guide. 5th ed. New York, New York: Cambridge University Press; 2014. pp. 697-99
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. p. 1405
Trihexyphnidyl. Huddersfield, West Yorkshire: Genus Pharmaceuticals; 2011 (19 Mar. 2019)
Jilani TN, Sharma S. Trihexyphenidyl (20 Jun. 2019)
Drugs and Lactation Database (LactMed) (20 Feb. 2020)
Central Drugs Standard Control Organisation (CDSCO) (19 Mar. 2019)
Trihexyphenidyl HCl (25 Jul. 2024)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
